Literature DB >> 29483670

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.

Anna Norberg1, Anna Rosén2,3, Klas Raaschou-Jensen4, Lars Kjeldsen5, Jukka S Moilanen6,7, Ylva Paulsson-Karlsson8,9, Panagiotis Baliakas8,9, Olli Lohi10, Aymen Ahmed11, Astrid O Kittang11, Pär Larsson2, Göran Roos12, Sofie Degerman12, Magnus Hultdin12.   

Abstract

Telomere-related disorders are a clinically and genetically heterogeneous group of disorders characterized by premature telomere shortening and proliferative failure of a variety of tissues. This study reports the spectrum of telomere-related gene variants and telomere length in Nordic patients referred for genetic testing due to suspected telomere-related disorder. We performed Sanger sequencing of the genes TERT, TERC, DKC1, and TINF2 on 135 unrelated index patients and measured telomere length by qPCR on DNA from peripheral blood leukocytes. We identified pathogenic or likely pathogenic variants in 10 index patients, all of which had short telomeres compared to age-matched healthy controls. Six of the 10 variants were novel; three in TERC (n.69_74dupAGGCGC, n.122_125delGCGG, and n.407_408delinsAA) and three in TERT (p.(D684G), p.(R774*), and p.(*1133Wext*39)). The high proportion of novel variants identified in our study highlights the need for solid interpretation of new variants that may be detected. Measurement of telomere length is a useful approach for evaluating pathogenicity of genetic variants associated with telomere-related disorders.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29483670      PMCID: PMC5974393          DOI: 10.1038/s41431-018-0112-8

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  46 in total

1.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

2.  TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.

Authors:  Hong-Yan Du; Elena Pumbo; Jennifer Ivanovich; Ping An; Richard T Maziarz; Ulrike M Reiss; Deborah Chirnomas; Akiko Shimamura; Adrianna Vlachos; Jeffrey M Lipton; Rakesh K Goyal; Frederick Goldman; David B Wilson; Philip J Mason; Monica Bessler
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

3.  Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.

Authors:  Lina Basel-Vanagaite; Inderjeet Dokal; Hannah Tamary; Abraham Avigdor; Ben Zion Garty; Alexander Volkov; Tom Vulliamy
Journal:  Haematologica       Date:  2008-05-06       Impact factor: 9.941

4.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

5.  Telomerase gene mutations are associated with cirrhosis formation.

Authors:  Daniel Hartmann; Ujala Srivastava; Michaela Thaler; Karin N Kleinhans; Gisèle N'kontchou; Annika Scheffold; Kerstin Bauer; Ramona F Kratzer; Natalia Kloos; Sarah-Fee Katz; Zhangfa Song; Yvonne Begus-Nahrmann; Alexander Kleger; Guido von Figura; Pavel Strnad; André Lechel; Cagatay Günes; Andrej Potthoff; Katja Deterding; Heiner Wedemeyer; Zhenyu Ju; Ge Song; Feng Xiao; Sonja Gillen; Hubert Schrezenmeier; Thomas Mertens; Marianne Ziol; Helmut Friess; Michael Jarek; Michael P Manns; Michel Beaugrand; K Lenhard Rudolph
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

6.  Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability.

Authors:  Tangui Le Guen; Laurent Jullien; Fabien Touzot; Michael Schertzer; Laetitia Gaillard; Mylène Perderiset; Wassila Carpentier; Patrick Nitschke; Capucine Picard; Gérard Couillault; Jean Soulier; Alain Fischer; Isabelle Callebaut; Nada Jabado; Arturo Londono-Vallejo; Jean-Pierre de Villartay; Patrick Revy
Journal:  Hum Mol Genet       Date:  2013-04-15       Impact factor: 6.150

7.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

8.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

9.  Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.

Authors:  R T Calado; J A Regal; S Kajigaya; N S Young
Journal:  Eur J Clin Invest       Date:  2009-08-11       Impact factor: 4.686

10.  A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.

Authors:  Clemens Stockklausner; Simon Raffel; Julia Klermund; Obul Reddy Bandapalli; Fabian Beier; Tim H Brümmendorf; Friederike Bürger; Sven W Sauer; Georg F Hoffmann; Holger Lorenz; Laura Tagliaferri; Daniel Nowak; Wolf-Karsten Hofmann; Rebecca Buergermeister; Carolin Kerber; Tobias Rausch; Jan O Korbel; Brian Luke; Andreas Trumpp; Andreas E Kulozik
Journal:  Aging (Albany NY)       Date:  2015-11       Impact factor: 5.682

View more
  7 in total

Review 1.  Genetics of human telomere biology disorders.

Authors:  Patrick Revy; Caroline Kannengiesser; Alison A Bertuch
Journal:  Nat Rev Genet       Date:  2022-09-23       Impact factor: 59.581

Review 2.  Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.

Authors:  Valentino Bezzerri; Martina Api; Marisole Allegri; Benedetta Fabrizzi; Seth J Corey; Marco Cipolli
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

3.  The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females.

Authors:  Qing Sun; Junli Liu; Guanghui Cheng; Mingkai Dai; Jiaxi Liu; Zhenqiang Qi; Jingjie Zhao; Wei Li; Feng Kong; Gang Liu; Magnus Björkholm; Dawei Xu
Journal:  J Transl Med       Date:  2020-05-04       Impact factor: 5.531

4.  Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal-Hreidarsson syndrome.

Authors:  Ann Nordgren; Marianne Farnebo; Sofie Bergstrand; Stefanie Böhm; Helena Malmgren; Anna Norberg; Mikael Sundin
Journal:  Cell Death Dis       Date:  2020-04-17       Impact factor: 8.469

5.  Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia.

Authors:  Christoffer Stark; Juha W Koskenvuo; Antti Nykänen; Eija H Seppälä; Samuel Myllykangas; Karl Lemström; Peter Raivio
Journal:  ERJ Open Res       Date:  2022-01-24

6.  de Novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita.

Authors:  S A Kocheva; M Gjorgjievska; K Martinova; Z Antevska-Trajkova; A Jovanovska; D Plaseska-Karanfilska
Journal:  Balkan J Med Genet       Date:  2022-06-05       Impact factor: 0.810

7.  A Case Series of TERC Variant Telomere Biology Disorders in Unrelated Families From Atlantic Canada.

Authors:  Amye M Harrigan; Shelley MacDonald; Bruce Crooks; Sarah Dyack; Amy M Trottier
Journal:  J Hematol       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.